Martin Würmli

Kantonsspital St.Gallen is a major tertiary referral center for eastern Switzerland and one of the largest hospitals in the region. The hospital is based in St. Gallen, Switzerland, and is a combination of St. Gallen, Rorschach, and Flawil hospitals, offering a wide range of high-quality services to ensure the medical basic and special care of eastern Switzerland. With over 6,000 employees, the hospital is committed to providing evidence-based care and treatment to its patients. The hospital also conducts strong basic, translational, and clinical research to offer patients access to validated interventions and novel treatments. Daniel Germann has been the CEO of the Swiss company since 1998.